Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI(®) induces enhanced serological, cellular and protective immune responses

Avian influenza virus infection is a serious public health threat and preventive vaccination is the most cost-effective public health intervention strategy. Unfortunately, currently available unadjuvanted avian influenza vaccines are poorly immunogenic and alternative vaccine formulations and delive...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Weiping, Mishina, Margarita, Amoah, Samuel, Mboko, Wadzanai P., Bohannon, Caitlin, McCoy, James, Mittal, Suresh K., Gangappa, Shivaprakash, Sambhara, Suryaprakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058713/
https://www.ncbi.nlm.nih.gov/pubmed/29542358
http://dx.doi.org/10.1080/10717544.2018.1450909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058713/
https://www.ncbi.nlm.nih.gov/pubmed/29542358
http://dx.doi.org/10.1080/10717544.2018.1450909

Ejemplares similares